» Articles » PMID: 21123286

Risk Factors for Fluoroquinolone-resistant Escherichia Coli in Adults with Community-onset Febrile Urinary Tract Infection

Abstract

Objectives: To assess risk factors for fluoroquinolone resistance in community-onset febrile Escherichia coli urinary tract infection (UTI).

Methods: A nested case-control study within a cohort of consecutive adults with febrile UTI presenting at primary healthcare centres or emergency departments during January 2004 through December 2009. Resistance was defined using EUCAST criteria (ciprofloxacin MIC >1.0 mg/L). Cases were subjects with fluoroquinolone-resistant E. coli, and controls those with fluoroquinolone-susceptible isolates. Multivariable logistic regression analysis was used to identify potential risk factors for fluoroquinolone resistance.

Results: Of 787 consecutive patients, 420 had E. coli-positive urine cultures. Of these, 51 (12%) were fluoroquinolone resistant. Independent risk factors for fluoroquinolone resistance were urinary catheter [odds ratio (OR) 3.1; 95% confidence interval (CI) 0.9-11.6], recent hospitalization (OR 2.0; 95% CI 1.0-4.3) and fluoroquinolone use in the past 6 months (OR 17.5; 95% CI 6.0-50.7). Environmental factors (e.g. contact with animals or hospitalized household members) were not associated with fluoroquinolone resistance. Of fluoroquinolone-resistant strains, 33% were resistant to amoxicillin/clavulanate and 65% to trimethoprim/sulfamethoxazole; 14% were extended-spectrum β-lactamase (ESBL) positive compared with <1% of fluoroquinolone-susceptible isolates.

Conclusions: Recent hospitalization, urinary catheter and fluoroquinolone use in the past 6 months were independent risk factors for fluoroquinolone resistance in community-onset febrile E. coli UTI. Contact with animals or hospitalized household members was not associated with fluoroquinolone resistance. Fluoroquinolone resistance may be a marker of broader resistance, including ESBL positivity.

Citing Articles

Antimicrobial resistance of clinical Enterobacterales isolates from urine samples, Germany, 2016 to 2021.

Stoltidis-Claus C, Rosenberger K, Mandraka F, Quante X, Gielen J, Hoffmann D Euro Surveill. 2023; 28(19).

PMID: 37166759 PMC: 10176829. DOI: 10.2807/1560-7917.ES.2023.28.19.2200568.


Assessment of the Compliance of Cystitis Management According to French Recommendations through the Analysis of Prescriptions Collected in Community Pharmacies.

Piraux A, Hammoud R, Riou J, Lebdai S, Faure S Antibiotics (Basel). 2022; 11(7).

PMID: 35884230 PMC: 9312117. DOI: 10.3390/antibiotics11070976.


Association Between Aortic Aneurysm and Aortic Dissection With Fluoroquinolones Use in Patients With Urinary Tract Infections: A Population-Based Cohort Study.

Chen Y, Yang S, Yeh H, Yeh Y, Huang J, Tsao S J Am Heart Assoc. 2022; 11(6):e023267.

PMID: 35229623 PMC: 9075302. DOI: 10.1161/JAHA.121.023267.


Microbiological Species and Antibiotic Resistance in Diabetic and Nondiabetic Lower Extremity Wounds: A Comparative Cross-Sectional Study.

Dos Santos V, de Andrade Barberino M, Alves C Int J Low Extrem Wounds. 2021; 23(2):338-346.

PMID: 34747258 PMC: 11059827. DOI: 10.1177/15347346211053936.


Fluoroquinolone resistant bacterial isolates from the urinary tract among patients attending hospitals in Bushenyi District, Uganda.

Odoki M, Aliero A, Tibyangye J, Maniga J, Eilu E, Ntulume I Pan Afr Med J. 2020; 36:60.

PMID: 32733630 PMC: 7371443. DOI: 10.11604/pamj.2020.36.60.18832.